Perrigo Company announced that it has received final approval from the US Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the company's fiscal first quarter 2011. Cherry joins the currently available grape flavour cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavours.

The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare's Zyrtec Children's Allergy Syrup, indicated for indoor and outdoor allergy relief. Brand sales for the Zyrtec brand of products, which includes cherry syrup, were $580 million for the last 52 weeks ending July 4, 2010.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.